All COVID-19 articles – Page 25
-
NewsVIDEO: Jonathan Van-Tam awarded Honorary Fellowship by Applied Microbiology International
Former Deputy Chief Medical Officer Jonathan Van-Tam was awarded an Honorary Fellowship by Applied Microbiology International at a glittering awards ceremony in London’s Science Museum this November.
-
CareersVIDEO: Jonathan Van-Tam fields questions from early career scientists at Applied Microbiology International Awards 2022
Former Deputy Chief Medical Officer Jonathan Van-Tam delivered fascinating insights during a Q&A session with early career scientists at the Applied Microbiology International Awards 2022.
-
NewsOlfactory viral inflammation linked to accelerated onset of Alzheimer’s disease
Viruses can inflame and disrupt connections between the olfactory system, which governs the sense of smell, and the part of the brain associated with memory and learning, possibly accelerating the onset of Alzheimer’s disease, according to a new study.
-
NewsScientists identify infection-halting compound that can target hosts, not viruses
Researchers at UBC’s Life Sciences Institute have identified a compound that shows early promise at halting infections from a range of coronaviruses, including all variants of SARS-CoV-2 and the common cold.
-
NewsMachine learning tool figures out how many people are represented in a wastewater sample
A machine learning model has been developed that uses the assortment of microbes in wastewater to find out how many individual people they represent.
-
NewsLiquid-coated air filter inspired by carnivorous plant can improve early capture of airborne pathogens
Researchers have designed a new liquid-coated air filter that allows for improved early detection and analysis of airborne bacteria and viruses, including the one that causes COVID-19.
-
NewsResearchers find new viral entryway into host cells for Covid-19
A University of Ottawa-led team has found a new viral entry for SARS-CoV-2, suggesting it may be able to use proteins to infect a wider range of cells.
-
NewsNew £1.7m containment facility will help prepare for future pandemics
A £1.7m laboratory building which will investigate infectious diseases has opened at the University of Warwick – helping to tackle some of the most globally important human diseases and prepare for pandemics of the future.
-
NewsImmune response discovery solves mystery of why colds are more common when it’s cold
Scientists say a newly discovered immune response inside the nose is suppressed by colder temperatures, offering evidence for why colds, flu and COVID-19 are more common in cooler months.
-
NewsWireless device can rapidly spot coronavirus using magnetostrictive composite plates
A collaborative research group has engineered a self-sustaining device that can immediately detect COVID-19 particles in its surroundings.
-
NewsClover’s vaccine candidate reduced household transmission of SARS-CoV-2
A collaboration between Clover Biopharmaceuticals Ltd and the International Vaccine Institute showed that a household contact was 84% less likely to get a SARS-CoV-2 infection when the infected household member had received SCB-2019 (CpG 1018/Alum) compared to placebos.
-
NewsCOVID-19 infection disrupts gut microbes, especially with antibiotics
Acute infection disrupts a healthy balance between good and bad microbes in the gut, especially with antibiotic treatment, researchers have found.
-
NewsResearchers develop tailored Covid neutralizer that can adapt to mutations
A research team at Pohang University of Science and Technology has developed a tailored COVID-19 neutralizer that can adapt to all kinds of mutations in the virus in treating the viral infection.
-
NewsNew Omicron subvariant resistant to all approved therapeutic antibodies
Rrsearchers in Germany have found that the Omicron sub-lineage BQ.1.1, currently on the rise worldwide, is resistant to all the approved antibody therapies used to treat individuals at risk for severe Covid-19 disease.
-
NewsHidden Nsp1 cavity means Covid’s Spike protein is no longer the only target
Researchers have revealed the existence of a hidden ’’pocket’ on the surface of the non-structural protein Nsp1 on the surface of the Covid-19 virus which could offer a potential drug target and alternative to the Spike protein targeted by vaccines.
-
NewsCOVID-19 reanimates latent viruses in cells – particularly in ME patients
Researchers have found that COVID-19 reactivates viruses that had become latent in cells following previous infections, particularly in people with chronic fatigue syndrome, also known as ME/CFS.
-
NewsSARS-CoV-2 alters functioning of RNA in infected cells
Researchers have shown that infection by SARS-CoV-2, the virus that causes COVID-19, changes the functioning of host cell RNA.
-
NewsCoffee compound could offer protection from catching COVID-19
Researchers have shown that a compound found in coffee could help to protect against infection by Covid-19.
-
NewsCOVID-19 virus increases risk of other infections by disrupting normal mix of gut bacteria
Infection with Covid-19 can reduce the number of bacterial species in a patient’s gut, with the lesser diversity creating space for dangerous microbes to thrive, a new study has found.
-
NewsResearchers find SARS-CoV-2 Omicron BA.2 subvariant less severe than earlier variants
team led by investigators at Massachusetts General Hospital (MGH) has determined that the SARS-CoV-2 Omicron BA.2 subvariant is less severe than the previous Delta variant and less severe to an even greater extent than the original Omicron variant.